DJIA 17,071.22 -41.93 -0.25%
NASDAQ 4,505.85 -6.34 -0.14%
S&P 500 1,977.80 -5.05 -0.25%
market minute promo

Allergan, Inc. (NYSE: AGN)

179.70 1.70 (0.96%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AGN $179.70 0.96%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $177.07
Previous Close $178.00
Daily Range $175.53 - $181.94
52-Week Range $88.34 - $181.94
Market Cap $53.4B
P/E Ratio 40.83
Dividend (Yield) $0.20 (0.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,260,112
Average Daily Volume 1,748,989
Current FY EPS $5.79





Allergan, Inc. (AGN) Description

A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc. Website:

News & Commentary

3 Questions for Allergan Inc.

Allergan is fighting tooth and nail to remain independent from Valeant Pharmaceuticals. Here are three questions investors should know the answers to heading into what is looking like the endgame.

Today's Stocks Driving Success For The Drugs Industry

5 Rocket Stocks to Buy to Avoid the Selloff

3 Likely Biotech Buyout Candidates

UPDATE: Allergan Board Offers Statement, Says Valeant's Bid 'Grossly Inadequate'

Wall Street Breakfast: Billions Withdrawn From Pimco Following Gross's Departure

Why Main Street Fails

Jackson Square Partners Joins Investors Opposing Allergan Bid for Salix

Allergan Writes Back, Coaxes Shareholders Against Valeant - Analyst Blog

Allergan Writes Back, Coaxes Shareholders Against Valeant - Analyst Blog

Why Allergan (AGN) Stock Is Declining in After-Hours Trading Today

Can Valeant's Glaucoma Drug Peak Sales Be Much Lower Than Claimed?

See More AGN News...

AGN's Top Competitors

AGN $179.70 (0.96%)
Current stock: AGN
JNJ $106.54 (-0.52%)
Current stock: JNJ
PFE $29.77 (0.17%)
Current stock: PFE
RHHBY $36.90 (-0.24%)
Current stock: RHHBY